Jiangxi Sanxin Medtec Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Revenue	1,684	1,636	1,497	1,296	1,334	1,164
Other Revenue	4.02	4.02	3.85	3.66	2.38	-
Revenue	1,688	1,640	1,500	1,300	1,336	1,164
Revenue Growth (YoY)	10.37%	9.31%	15.41%	-2.69%	14.75%	23.81%
Cost of Revenue	1,077	1,056	972.05	847.27	886.52	763.96
Gross Profit	611	584.1	528.39	452.79	449.49	400.33
Selling, General & Admin	203.39	200.44	192.01	169.71	193.43	158.38
Research & Development	76.83	75.28	63.98	51.07	40.85	42.15
Other Operating Expenses	9.66	9.1	5.15	9.21	10.24	11.12
Operating Expenses	295.21	288.98	265.17	230.83	245.57	213.34
Operating Income	315.78	295.12	263.22	221.96	203.91	186.98
Interest Expense	-2.1	-1.82	-3.11	-4.52	-2.95	-2.08
Interest & Investment Income	12.16	11.69	12.44	16.01	5.71	2.13
Currency Exchange Gain (Loss)	1.31	1.31	2.92	0.76	1.57	1.78
Other Non Operating Income (Expenses)	-1.8	-0.78	-0.23	-1.15	-1.09	-4.62
EBT Excluding Unusual Items	325.35	305.53	275.24	233.06	207.16	184.19
Gain (Loss) on Sale of Investments	1	0.11	-11.02	1.3	1.17	-0.46
Gain (Loss) on Sale of Assets	-0.71	-0.85	0.19	0.16	0.01	-0.89
Asset Writedown	-1.89	-1.69	-1.1	-0.38	-6.71	-3.22
Other Unusual Items	21.15	21.15	12.75	18.64	23.99	15.76
Pretax Income	344.91	324.24	276.06	252.77	225.61	195.37
Income Tax Expense	38.59	33.97	28.36	29.54	26.52	23.56
Earnings From Continuing Operations	306.32	290.27	247.7	223.23	199.1	171.81
Minority Interest in Earnings	-26.75	-25.33	-20.3	-16.6	-14.46	-15.9
Net Income	279.57	264.94	227.4	206.63	184.63	155.91
Net Income to Common	279.57	264.94	227.4	206.63	184.63	155.91
Net Income Growth	22.88%	16.50%	10.05%	11.92%	18.42%	34.84%
Shares Outstanding (Basic)	517	518	515	518	515	507
Shares Outstanding (Diluted)	517	518	516	519	515	513
Shares Change (YoY)	-0.02%	0.36%	-0.53%	0.71%	0.35%	-0.53%
EPS (Basic)	0.54	0.51	0.44	0.40	0.36	0.31
EPS (Diluted)	0.54	0.51	0.44	0.40	0.36	0.30
EPS Growth	22.90%	16.08%	10.64%	11.13%	18.00%	35.56%
Free Cash Flow	183.26	218.73	172.05	52.34	191.62	154.91
Free Cash Flow Per Share	0.35	0.42	0.33	0.10	0.37	0.30
Dividend Per Share	0.300	0.300	0.300	0.115	0.115	0.115
Dividend Growth	-	-	159.97%	-	-	12.58%
Gross Margin	36.19%	35.61%	35.22%	34.83%	33.64%	34.38%
Operating Margin	18.70%	17.99%	17.54%	17.07%	15.26%	16.06%
Profit Margin	16.56%	16.15%	15.16%	15.89%	13.82%	13.39%
Free Cash Flow Margin	10.85%	13.34%	11.47%	4.03%	14.34%	13.31%
EBITDA	442.17	414.14	352.76	294.72	267.06	242.54
EBITDA Margin	26.19%	25.25%	23.51%	22.67%	19.99%	20.83%
D&A For EBITDA	126.39	119.02	89.54	72.76	63.14	55.55
EBIT	315.78	295.12	263.22	221.96	203.91	186.98
EBIT Margin	18.70%	17.99%	17.54%	17.07%	15.26%	16.06%
Effective Tax Rate	11.19%	10.48%	10.27%	11.68%	11.75%	12.06%
Revenue as Reported	1,688	1,640	1,500	1,300	1,336	1,164
Advertising Expenses	-	8.68	7.52	1.97	4.66	8.16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.